Robert Palmisano - Wright Medical CEO and President and Executive Director

CEO

Mr. Robert J. Palmisano has served as President and Chief Executive Officer and Executive Director of Wright Medical Group N.V. since October 2015. Mr. Palmisano has served as President and Chief Executive Officer of Wright Medical Group, Inc. since September 2011. Prior to joining Wright, Mr. Palmisano served as President and Chief Executive Officer of ev3 Inc., a global endovascular device company, from April 2008 to July 2010, when it was acquired by Covidien plc. From 2003 to 2007, Mr. Palmisano was President and Chief Executive Officer of IntraLase Corporationration Before joining IntraLase, Mr. Palmisano was President and Chief Executive Officer of MacroChem Corporation from 2001 to 2003. Mr. Palmisano currently serves on the Providence College Board of Trustees since 2015.
Age 72
Tenure 9 years
Phone31 20 521 4777
Webhttp://www.wright.com
Palmisano previously served on the board of directors of ev3 Inc., Osteotech, Inc. and Abbott Medical Optics, Inc., all publicly held companies, and Bausch & Lomb, a privately held company.

Wright Medical Management Efficiency

The company has return on total asset (ROA) of 0.16 % which means that it generated a profit of $0.16 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (10.35) %, meaning that it created substantial loss on money invested by shareholders. Wright Medical's management efficiency ratios could be used to measure how well Wright Medical manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 1.22 B in liabilities with Debt to Equity (D/E) ratio of 1.43, which is about average as compared to similar companies. Wright Medical Group has a current ratio of 0.82, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Wright Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Wright Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Wright Medical Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Wright to invest in growth at high rates of return. When we think about Wright Medical's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 3 records

CEO Age

Anne NoonanSummit Materials
61
Thomas HillSummit Materials
63
Jose BoisjoliBRP Inc
66
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company was founded in 1999 and is headquartered in Amsterdam, the Netherlands. Wright Medical is traded on NASDAQ Exchange in the United States. Wright Medical Group (WMGI) is traded on NASDAQ Exchange in USA and employs 3,030 people.

Management Performance

Wright Medical Group Leadership Team

Elected by the shareholders, the Wright Medical's board of directors comprises two types of representatives: Wright Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Wright. The board's role is to monitor Wright Medical's management team and ensure that shareholders' interests are well served. Wright Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Wright Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Julie Dewey, Senior Vice President and Chief Communications Officer, IR Contact Officer
Elizabeth Weatherman, Non-Executive Independent Director
David Mowry, COO, Executive VP and Executive Director
James Lightman, Senior Vice President General Counsel, Secretary
Lance Berry, CFO and Sr. VP
David Stevens, Independent Chairman of the Board
Kevin OBoyle, Interim Non-Executive Independent Vice Chairman of the Board
Robert Burrows, Senior Vice President - Supply Chain
Julie Andrews, Chief Accounting Officer and VP of Fin.
Patrick Fisher, President Lower Extremities
Gary Blackford, Independent Director
Peter Cooke, President of International
Kevin Cordell, President of Lower Extremities and Biologics
Jennifer Walker, Senior Vice President - Process Improvement
Robert Palmisano, CEO and President and Executive Director
Richard Wallman, Non-Executive Independent Director
Terry Rich, Senior Vice President - U.S. Commercial Operations
William Griffin, Senior Vice President; General Manager, BioMimetic Therapeutics
Jason Asper, Senior Vice President Strategy and Corporate Development
Amy Paul, Independent Director
Gregory Morrison, Senior Vice President-Global Human resources
JWesley Porter, Senior Vice President Chief Compliance Officer
Sean Carney, Non-Executive Independent Chairman of the Board
Julie Tracy, Senior Vice President Chief Communications Officer
Timothy Lanier, President Upper Extremities
John Miclot, Independent Director

Wright Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Wright Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Wright Medical Group information on this page should be used as a complementary analysis to other Wright Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Consideration for investing in Wright Stock

If you are still planning to invest in Wright Medical Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Wright Medical's history and understand the potential risks before investing.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm